In a surprising turn, Kobayashi Pharmaceutical, the embattled drugmaker at the center of a health scandal involving its beni kōji (red yeast rice) dietary supplements, [more…]
The Thai consulate in Osaka has issued an unusual health advisory for Thai nationals residing or traveling in Osaka, Japan, following the confirmation of measles [more…]
Celltrion, the pioneering Korean biopharmaceuticals firm, has made a significant stride in the US market with the launch of its groundbreaking autoimmune disease treatment, Zymfentra. [more…]
The arrival of Opill, the first over-the-counter oral contraceptive in the United States, marks a significant milestone in reproductive health accessibility. With a manufacturer’s suggested [more…]
Viking Therapeutics surged approximately 80% on Tuesday following the announcement of promising results from its mid-stage trial of an experimental weight loss drug. The drug, [more…]
Eisai plans to introduce its groundbreaking Alzheimer’s drug, Leqembi, to 1,500 people in China this year, with expectations of significant growth in 2025 as diagnosis [more…]
In a sobering turn of events, Japan has reported its first death from mpox, a viral disease that has been causing concern since its first [more…]
In a monumental stride forward in medical science, the U.S. Food and Drug Administration (FDA) has granted approval for the first gene-editing treatment for sickle [more…]
In a concerning turn of events, South Korea is grappling with a resurgence of highly pathogenic avian influenza (AI) as health authorities confirmed a second [more…]
In the heart of Rio de Janeiro, where the rhythms of samba once danced in harmony with a groundbreaking movement to provide affordable HIV treatment, [more…]
